Cargando…
Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
BACKGROUND: Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson’s disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic system and meningeal lymphatic v...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396507/ https://www.ncbi.nlm.nih.gov/pubmed/30867902 http://dx.doi.org/10.1186/s40035-019-0147-y |
_version_ | 1783399267352707072 |
---|---|
author | Zou, Wenyan Pu, Tinglin Feng, Weixi Lu, Ming Zheng, Ying Du, Renhong Xiao, Ming Hu, Gang |
author_facet | Zou, Wenyan Pu, Tinglin Feng, Weixi Lu, Ming Zheng, Ying Du, Renhong Xiao, Ming Hu, Gang |
author_sort | Zou, Wenyan |
collection | PubMed |
description | BACKGROUND: Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson’s disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic system and meningeal lymphatic vessels in the clearance of brain macromolecules, however, their pathophysiological aspects remain elusive. METHOD: Meningeal lymphatic drainage of 18-week-old A53T mice was blocked via ligating the deep cervical lymph nodes. Six weeks later, glymphatic functions and PD-like phenotypes were systemically analyzed. RESULTS: Glymphatic influx of cerebrospinal fluid tracer was reduced in A53T mice, accompanied with perivascular aggregation of α-synuclein and impaired polarization of aquaporin 4 expression in substantia nigra. Cervical lymphatic ligation aggravated glymphatic dysfunction of A53T mice, causing more severe accumulation of α-synuclein, glial activation, inflammation, dopaminergic neuronal loss and motor deficits. CONCLUSION: The results suggest that brain lymphatic clearance dysfunction may be an aggravating factor in PD pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0147-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6396507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63965072019-03-13 Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein Zou, Wenyan Pu, Tinglin Feng, Weixi Lu, Ming Zheng, Ying Du, Renhong Xiao, Ming Hu, Gang Transl Neurodegener Research BACKGROUND: Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson’s disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic system and meningeal lymphatic vessels in the clearance of brain macromolecules, however, their pathophysiological aspects remain elusive. METHOD: Meningeal lymphatic drainage of 18-week-old A53T mice was blocked via ligating the deep cervical lymph nodes. Six weeks later, glymphatic functions and PD-like phenotypes were systemically analyzed. RESULTS: Glymphatic influx of cerebrospinal fluid tracer was reduced in A53T mice, accompanied with perivascular aggregation of α-synuclein and impaired polarization of aquaporin 4 expression in substantia nigra. Cervical lymphatic ligation aggravated glymphatic dysfunction of A53T mice, causing more severe accumulation of α-synuclein, glial activation, inflammation, dopaminergic neuronal loss and motor deficits. CONCLUSION: The results suggest that brain lymphatic clearance dysfunction may be an aggravating factor in PD pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0147-y) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-01 /pmc/articles/PMC6396507/ /pubmed/30867902 http://dx.doi.org/10.1186/s40035-019-0147-y Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zou, Wenyan Pu, Tinglin Feng, Weixi Lu, Ming Zheng, Ying Du, Renhong Xiao, Ming Hu, Gang Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
title | Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
title_full | Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
title_fullStr | Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
title_full_unstemmed | Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
title_short | Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
title_sort | blocking meningeal lymphatic drainage aggravates parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396507/ https://www.ncbi.nlm.nih.gov/pubmed/30867902 http://dx.doi.org/10.1186/s40035-019-0147-y |
work_keys_str_mv | AT zouwenyan blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT putinglin blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT fengweixi blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT luming blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT zhengying blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT durenhong blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT xiaoming blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein AT hugang blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein |